Physician profile
Rommel Kaur Bal
NPI 1730264219
$2,092.27
in general payments reported to CMS, 2019-2025
11 companies · $50.42 in 2025
The $50.42 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $106 · 2021: $267 · 2022: $1,176 · 2023: $18.80 · 2024: $296 · 2025: $50.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194 · Entertainment: $64.53 · Education: $64.53 · Gift: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.06 |
| Entertainment | $64.53 |
| Education | $64.53 |
| Gift | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,237.52 | 2022-2024 | Suresmile |
| A-Dec, INC. | $208.00 | 2019-2024 | |
| Align Technology, INC. | $204.30 | 2020-2021 | |
| Ultradent Products INC | $152.49 | 2021 | |
| Kuraray America INC. | $110.40 | 2022 | |
| Straumann USA LLC | $60.72 | 2022 | |
| 3m Company | $37.68 | 2019-2022 | |
| Dmg America LLC | $33.00 | 2025 | |
| Carestream Dental, LLC | $17.42 | 2025 | |
| Philips North America LLC | $15.84 | 2020 | |
| Colgate Oral Pharmaceuticals, INC. | $14.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rommel Bal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.